Skip to main content
Fig. 4 | Genome Medicine

Fig. 4

From: Gut microbiome for predicting immune checkpoint blockade-associated adverse events

Fig. 4

Identification of minimal features for the best model performance and multiple metrics for model evaluation. A Average AUC of ten-fold Random Forest cross-validation, study-to-study transfer validation classifiers, and LOSO validation for non-irAEs versus irAEs with a different number of features. B Comparison of RF score distributions calculated by RF14 classifier between non-irAEs (n = 113) and irAEs (n = 77) groups. Two-sided P values were calculated using the Wilcoxon rank-sum test. C Performance measurements of RF14 classifier illustrated by sensitivity, specificity, accuracy, positive predictive value (PPV), and negative predictive value (NPV). D The comparison of microbiome model specificity between irAEs and response. The anti-PD1/PD-L1 cohorts comprising over 50 patients, such as those led by Zhang et al., Hakozaki et al., and McCulloch et al., were utilized for the analysis in this part

Back to article page